ALB and hepatorenal syndrome: The correct subphenotyping can guide clinical management using fluid resuscitation (albumin) alone for hypovolemia, or addition of vasopressor therapy (e.g., terlipressin) for fluid-refractory hepatorenal syndrome, versus supportive care and additional diagnostic testing for intrinsic AKI.